Evidence map›Paper›PMID 25183764›Full record

ArticleInvestigative ophthalmology & visual science2014

The role of toll-like receptor 4 in corneal epithelial wound healing.

Medi Eslani, Asadolah Movahedan, Neda Afsharkhamseh, Herve Sroussi, Ali R Djalilian

Open access · hybridAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Innate Immune System Activation, Inflammation and Corneal Wound Healing.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Xylose-Inducible Promoter Tools forApplied and environmental microbiology · 2020
    Article
  12. Article
  13. Dioleoylphosphatidylglycerol Accelerates Corneal Epithelial Wound Healing.Investigative ophthalmology & visual science · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Medi EslaniDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States.
Asadolah MovahedanDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States.
Neda AfsharkhamsehDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States.
Herve SroussiOral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois at Chicago, Chicago, Illinois, United States.
Ali R DjalilianDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States.
University of Illinois Chicago · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YAO, XINCHENG · 1985 to 2025
$14.8M
Notch Signaling in the Corneal EpitheliumK08EY017561 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DJALILIAN, ALI R · 2007 to 2011
$1.3M
NEI NIH HHS EY01792NEI NIH HHS K08 EY017561NEI NIH HHS K08EY017561-A1NEI NIH HHS P30 EY001792
6 · The paper itself

Abstract

purposeWe evaluated the role of Toll-like receptor 4 (TLR4) in corneal epithelial wound healing.

methodsThe expression of TLR4 during in vivo corneal epithelial wound healing was examined by immunostaining in mice. The expression and activation of TLR4 was studied in primary or telomerase-immortalized human corneal epithelial cells (HCEC). Scratch assay was performed to evaluate in vitro wound closure using live time-lapse microscopy. Transwell migration assay and Ki67 immunostaining were done to evaluate migration and proliferation, respectively. Lipopolysaccharide (LPS) was used to activate TLR4, whereas CLI-095 was used for its inhibition. The expression of inflammatory cytokines was determined by RT-PCR and ELISA. The activation of p42/44 and p38 was determined by immunoblotting.

resultsIn the murine model, TLR4 immunostaining was noted prominently in the epithelium 8 hours after wounding. There was a 4-fold increase in the expression of TLR4 6 hours after in vitro scratch wounding (P < 0.001). Confocal microscopy confirmed the membrane localization of TLR4/MD2 complex. There was a significant increase in migration, proliferation, and wound closure in HCEC treated with LPS (P < 0.05), while there was significant decrease with TLR4 inhibition (P < 0.05). Addition of LPS to wounded HCEC resulted in a significant increase in the expression of IL-6, TNF-α, CXCL8/IL8, and CCL5/RANTES at the mRNA and protein levels. Likewise, LPS increased the activation of p42/44 and p38 in wounded HCEC.

conclusionsThese results suggest that epithelial wounding induces the expression of functional TLR4. Toll-like receptor 4 signaling appears to contribute to early corneal epithelial wound repair by enhancing migration and proliferation.

Indexed as

Disease Models, AnimalAnimalsBlotting, WesternCell LineCell Migration AssaysCell MovementCell ProliferationCytokinesDebridementEnzyme-Linked Immunosorbent AssayEpithelium, CornealFluorescent Antibody Technique, IndirectGene Expression RegulationHumansImmunity, InnateKi-67 AntigenCytokinesKi-67 AntigenMAPK1 protein, humanMitogen-Activated Protein Kinase 1p38 Mitogen-Activated Protein KinasesTLR4 protein, humanToll-Like Receptor 4Transcription FactorsWDR77 protein, humancorneal epitheliumcorneal wound healinginnate immunityTLR4Toll-like receptor 4

Identifiers

PMID25183764
PMCPMC4179446
OpenAlexW2094537288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.